What drove Danaher's gross profit changes in 2023?

Danaher's gross profit for 2023 was $14.03 billion. The changes in Danaher's gross profit can be attributed to several key factors:

1. **Organic Revenue Growth**: Danaher's organic revenue rose 1.6% year-on-year. This indicates that the company's core business operations are growing, which would typically lead to higher gross profits.
2. **Acquisitions**: Acquisitions had a positive impact of 1.5% on segmental sales. This suggests that Danaher's strategic acquisitions are contributing to the overall revenue and, consequently, the gross profit.
3. **Foreign-Currency Translations**: Foreign-currency translations had an adverse impact of 0.5% on quarterly sales. This implies that fluctuations in currency markets are negatively affecting the company's revenue, and by extension, its gross profit.
4. **Segmental Performance**: Danaher's Life Sciences segment saw a 5.5% year-over-year increase in revenues. This strong performance in a specific segment can contribute positively to the overall gross profit. However, the Diagnostics segment experienced a 3% year-over-year decline in revenues, which could have a negative impact on the gross profit.

In summary, Danaher's gross profit changes in 2023 are driven by a combination of organic revenue growth, acquisitions, foreign-currency translations, and segmental performance, particularly in the Life Sciences segment.